Evidence status: CURRENT CHRONIC-PAIN MONITORING FRAMEWORK. Iowa’s physician rule places pain-management agreements inside a broader individualized treatment and monitoring framework.

Patient evaluation

Before treatment, the physician must conduct an evaluation including physical examination, medical history, pain assessment, and physical and psychological function. Substance-use history and prior interventions are part of the assessment.

Treatment plan

The physician must create an individualized treatment plan with objectives such as pain relief or improved function and identify planned diagnostics, treatment modalities, and rehabilitation when appropriate.

Informed consent

The risks and benefits of opioids must be discussed with the patient or representative and documented.

Periodic review

The physician must regularly review the patient’s opioid treatment course and pain source and reconsider drug therapy or other modalities when objectives are not being met or there are signs of diversion or substance abuse.

Drug testing

For opioid treatment extending beyond 90 days, the current rule says the physician should consider drug testing to assess therapeutic medication levels or when the physician believes the patient may be at risk of abuse or diversion. The rule does not impose one fixed statewide testing frequency.

Termination of care

The current rule says the physician should consider termination of care when there is evidence of noncompliance with medication-use rules, diversion, or a repeated pattern of substance abuse.

Primary source

• Iowa Administrative Code 481—655.2

Reviewed: October 4, 2026.

Evidence boundary: Drug testing, agreement use, and termination are risk-responsive components of Iowa’s physician standard; the current rule does not convert them into one universal fixed protocol for every chronic-pain patient.